Primary Cells Market - Global Industry Analysis

Primary Cells Market by Origin (Hematopoietic Cells, Renal Cells, Skin Cells, Lung Cells, Gastrointestinal Cells, Heart, Liver Cells, Skeletal and Muscle Cells, and Other Primary Cells), by Type (Human Primary Cells and Animal Primary Cells), and by End-User (Life Science Research Companies and Research Institutes): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Published Date: 02-Jan-2019 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-3689 Status : Published

Global primary cells market expected to generate around USD 13 billion by 2024, at a CAGR of around 5.5% between 2018 and 2024. Skin is vulnerable to a wide variety of toxins and microbes as it is the largest and most exposed organ. Prolonged exposure of skin to toxins results in various kinds of skin disorders.

Description

The report covers a forecast and an analysis of the primary cells market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the primary cells market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the primary cells market on a global level.

In order to give the users of this report a comprehensive view of the primary cells market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Primary Cells Market

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the primary cells market by segmenting the market based on origin, type, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

By origin, the primary cells market includes hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, renal cells, heart, skeletal and muscle cells, and other primary cells. By type, this market includes human primary cells and animal primary cells. Based on end-user, this global market includes life science research companies and research institutes. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Germany, Italy, France, UK, China, Japan, India, and Brazil.

The report also includes the detailed profiles of various market players, such as include Thermo Fisher Scientific, Merck KGaA, Lonza, Cell Biologics, PromoCell, ZenBio, STEMCELL Technologies, AllCells, American Type Culture Collection, and Axol Biosciences, among others.

This report segments the global primary cells market into:

Global Primary Cells Market: By Product

  • Hematopoietic Cells
  • Skin Cells
  • Gastrointestinal Cells
  • Liver Cells
  • Lung Cells
  • Renal Cells
  • Heart 
  • Skeletal and Muscle Cells
  • Other Primary Cells

Global Primary Cells Market: By Type

  • Human Primary Cells
  • Animal Primary Cells

Global Primary Cells Market: By End-User

  • Life Science Research Companies 
  • Research Institutes

Global Primary Cells Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Primary Cells Market, 2017 - 2024 (USD Billion)
    • 2.2. Global Primary Cells Market: Snapshot
  •  
  • Chapter 3. Primary Cells Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Primary Cells Market drivers: Impact analysis
      • 3.2.2. Increasing Cancer Research
      • 3.2.3. Advantages of Primary Human Cells Over Cell Lines
    • 3.3. Market Restraints
      • 3.3.1. Concerns Regarding Primary Cell Culture Contamination
    • 3.4. Opportunities
      • 3.4.1. Advancing Biomedical Research Using Primary Cells in 3D Culture
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Origin
      • 3.6.2. Market attractiveness analysis, by Type
      • 3.6.3. Market attractiveness analysis, by End-User
      • 3.6.4. Market attractiveness analysis, by Regional Segment
  •  
  • Chapter 4. Global Primary Cells Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Primary Cells Market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Primary Cells Market - Origin Segment Analysis
    • 5.1. Global Primary Cells Market: Origin overview
      • 5.1.1. Global Primary Cells Market revenue share, by Origin, 2017 and 2024(USD Billion)
    • 5.2. Hematopoietic Cells
      • 5.2.1. Global Hematopoietic Cells market, 2017 - 2024(USD Billion)
    • 5.3. Skin Cells
      • 5.3.1. Global Skin Cells market, 2017 - 2024(USD Billion)
    • 5.4. Gastrointestinal Cells
      • 5.4.1. Global Gastrointestinal Cells market, 2017 - 2024(USD Billion)
    • 5.5. Liver Cells
      • 5.5.1. Global Liver Cells market, 2017 - 2024(USD Billion)
    • 5.6. Lung Cells
      • 5.6.1. Global Lung Cells market, 2017 - 2024(USD Billion)
    • 5.7. Renal Cells
      • 5.7.1. Global Renal Cells market, 2017 - 2024(USD Billion)
    • 5.8. Heart
      • 5.8.1. Global Heart market, 2017 - 2024(USD Billion)
    • 5.9. Skeletal and Muscle Cells
      • 5.9.1. Global Skeletal and Muscle Cells market, 2017 - 2024(USD Billion)
    • 5.10. Other Primary Cells
      • 5.10.1. Global Other Primary Cells market, 2017 - 2024(USD Billion)
  •  
  • Chapter 6. Global Primary Cells Market - Type Segment Analysis
    • 6.1. Global Primary Cells Market: Type overview
      • 6.1.1. Global Primary Cells Market revenue share, by Type, 2017 and 2024(USD Billion)
    • 6.2. Human Primary Cells
      • 6.2.1. Global Primary Cells Market for Human Primary Cells, 2017 - 2024(USD Billion)
    • 6.3. Animal Primary Cells
      • 6.3.1. Global Primary Cells Market for Animal Primary Cells, 2017 - 2024(USD Billion)
  •  
  • Chapter 7. Global Primary Cells Market - End-User Segment Analysis
    • 7.1. Global Primary Cells Market: End-User overview
      • 7.1.1. Global Primary Cells Market revenue share, by End-User, 2017 and 2024(USD Billion)
    • 7.2. Life Science Research Companies
      • 7.2.1. Global Primary Cells Market for Life Science Research Companies, 2017 - 2024(USD Billion)
    • 7.3. Research Institutes
      • 7.3.1. Global Primary Cells Market for Research Institutes, 2017 - 2024(USD Billion)
  •  
  • Chapter 8. Global Primary Cells Market - Regional Segment Analysis
    • 8.1. Global Primary Cells Market: Regional overview
      • 8.1.1. Global Primary Cells Market revenue share, by Region, 2015 and 2021
    • 8.2. North America
      • 8.2.1. North America Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
      • 8.2.2. North America Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
      • 8.2.3. North America Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.2.4.2. The U.S. Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.2.4.3. The U.S. Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.2.5.2. Rest of North America Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.2.5.3. Rest of North America Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
      • 8.3.2. Europe Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
      • 8.3.3. Europe Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.3.4.2. Germany Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.3.4.3. Germany Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.3.5.2. UK Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.3.5.3. UK Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.3.6.2. France Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.3.6.3. France Primary Cells Market revenue, by End-User, 2017-2024(USD Billion)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.3.7.2. Rest of Europe Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.3.7.3. Rest of Europe Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
      • 8.4.2. Asia Pacific Primary Cells Market revenue, Type, 2017 - 2024(USD Billion)
      • 8.4.3. Asia Pacific Primary Cells Market revenue, End-User, 2017 - 2024(USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.4.4.2. China Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.4.4.3. China Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.4.5.2. Japan Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.4.5.3. Japan Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.4.6.2. India Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.4.6.3. India Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.4.7.2. Rest of Asia Pacific Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.4.7.3. Rest of Asia Pacific Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
      • 8.5.2. Latin America Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
      • 8.5.3. Latin America Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.5.4.2. Brazil Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.5.4.3. Brazil Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
        • 8.5.5.2. Rest of Latin America Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
        • 8.5.5.3. Rest of Latin America Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Primary Cells Market revenue, by Origin, 2017 - 2024(USD Billion)
      • 8.6.2. The Middle East and Africa Primary Cells Market Revenue, by Type, 2017 - 2024(USD Billion)
      • 8.6.3. The Middle East and Africa Primary Cells Market revenue, by End-User, 2017 - 2024(USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Thermo Fisher Scientific
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Merck KGaA
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Lonza
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Cell Biologics
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. PromoCell
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. ZenBio
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. STEMCELL Technologies
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. AllCells
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. American Type Culture Collection
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Axol Biosciences
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Therapy portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

Table Of Figures

List of Figures 

1. Market research process
2. Market research methodology
3. Global Primary Cells Market revenue, 2017 – 2024 (USD Billion) 
4. Porter’s Five Forces analysis
5. Primary Cells Market attractiveness analysis, by Origin segment
6. Primary Cells Market attractiveness analysis, by Type
7. Primary Cells Market attractiveness analysis, by End-User
8. Primary Cells Market: Market attractiveness analysis, by region
9. Company market share analysis, 2015
10. Global Primary Cells Market revenue share by Product, 2017 and 2024
11. Global Primary Cells Market, 2017 – 2024 (USD Billion)
a. Global Hematopoietic Cells market, 2017 – 2024(USD Billion)
b. Global Skin Cells market, 2017 – 2024(USD Billion)
c. Global Gastrointestinal Cells market, 2017 – 2024(USD Billion)
d. Global Liver Cells market, 2017 – 2024(USD Billion)
e. Global Lung Cells market, 2017 – 2024(USD Billion)
f. Global Renal Cells market, 2017 – 2024(USD Billion)
g. Global Heart market, 2017 – 2024(USD Billion)
h. Global Skeletal and Muscle Cells market, 2017 – 2024(USD Billion)
i. Global Other Primary Cells market, 2017 – 2024(USD Billion)
12. Global Primary Cells Market revenue share by Type, 2017 and 2024
13. Global Primary Cells Market, 2017 – 2024 (USD Billion)
a. Human Primary Cells, 2017 – 2024(USD Billion)
b. Animal Primary Cells, 2017 – 2024(USD Billion)
14. Global Primary Cells Market revenue share by End-User, 2017 and 2024
15. Global Primary Cells Market, 2017 – 2024 (USD Billion)
a. Life Science Research Companies, 2017 – 2024(USD Billion)
b. Research Institutes, 2017 – 2024(USD Billion)


Table Of Tables

List of Tables

1. Primary Cells Market: Market Snapshot                                                                                                                        
2. Drivers of global Primary Cells Market: Impact analysis 
3. Restraints of Primary Cells Market: Impact analysis
4. North America Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
5. North America Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion) 
6. North America Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion) 
7. The U.S. Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
8. The U.S. Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
9. The U.S. Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
10. Rest of North America Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
11. Rest of North America Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
12. Rest of North America Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
13. Europe Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
14. Europe Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
15. Europe Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
16. Germany Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
17. Germany Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
18. Germany Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
19. UK Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
20. UK Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
21. UK Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
22. France Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
23. France Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion) 
24. France Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion) 
25. Rest of Europe Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
26. Rest of Europe Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
27. Rest of Europe Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
28. Asia Pacific Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
29. Asia Pacific Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
30. Asia Pacific Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
31. China Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
32. China Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
33. China Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
34. Japan Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
35. Japan Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
36. Japan Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
37. India Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion)
38. India Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
39. India Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
40. Rest of Asia Pacific Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
41. Rest of Asia Pacific Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
42. Rest of Asia Pacific Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
43. Latin America Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
44. Latin America Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion)
45. Latin America Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)
46. Brazil Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
47. Brazil Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion) 
48. Brazil Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion) 
49. Rest of Latin America Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
50. Rest of Latin America Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion) 
51. Rest of Latin America Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion) 
52. The Middle East and Africa Primary Cells Market revenue, by Origin, 2017 – 2024(USD Billion) 
53. The Middle East and Africa Primary Cells Market Revenue, by Type, 2017 – 2024(USD Billion) 
54. The Middle East and Africa Primary Cells Market revenue, by End-User, 2017 – 2024(USD Billion)

Methodology

Free Analysis

Cells are building blocks of living organisms. The technique by which the performance of cells can be studied independently of the whole entity is known as cell culture. The culture cells from an animal or plant are taken and grown under favorable and artificially controlled conditions. Majorly, there are three types of cell culture procedures—primary cell culture, secondary cell culture, and cell line. Primary cells are extracted from tissues and treated under culture conditions for growth. Sub-culture of primary cells results into the secondary culture. The cell line is defined as a cell culture established from a single cell that has a constant genetic composition.

Cancer is one of the leading causes of death worldwide. In 2018, an estimated 9.6 million deaths occurred due to cancer. Globally, around 70% of deaths from cancer occur in lower- and middle-income countries. Additionally, advantages of primary human cells over cell lines, the demand for monoclonal antibodies, increased pharmaceutical outsourcing, partnerships, collaborations, and acquisitions, and rapid expansion witnessed across biotechnology and biopharmaceutical industries are anticipated to drive the primary cells market expansion globally in the upcoming years. However, the high cost of advanced primary cells and concerns pertaining to contamination related to primary cell culture might limit the primary cells market in the future. Nevertheless, the progressive biomedical research using primary cells in 3D culture is likely to open new growth avenues in this global market in the future.

Global Primary Cells Market

The primary cells market is classified market based on origin, type, and end-user. By origin, the primary cells market includes hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, renal cells, heart, skeletal and muscle cells, and other primary cells. The demand for liver cells is likely to grow in the upcoming years, due to their use in a wide range of applications across various pharmacological and toxicological studies. By type, this market includes human primary cells and animal primary cells. Based on end-user, this global market includes life science research companies and research institutes.

By region, North America is projected to lead the primary cells market globally. The rising occurrences of cancer and the expansion of pharmaceutical and biotechnology industries in the region are the major factors driving the growth of the primary cells market in North America. The Asia Pacific primary cells market is expected to register the highest CAGR in the forecast timeframe, due to a large number of cancer patients and the introduction of awareness programs, conferences, and funding activities.

Few of the key players in primary cells market include Thermo Fisher Scientific, Merck KGaA, Lonza, Cell Biologics, PromoCell, ZenBio, STEMCELL Technologies, AllCells, American Type Culture Collection, and Axol Biosciences, among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed